ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,983Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 1442

$2.61M Total Retail Price of All Prescriptions

Rank: 2 out of 1442

787 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 19,331 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

59% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$130 was the average price of a prescription from this provider, compared to $75 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 763 737 1 2
BYSTOLIC 707 679 2 32
AMLODIPINE BESYLATE 610 591 3 3
DIOVAN 606 581 4 19
DIOVAN HCT 604 587 5 35
ATORVASTATIN CALCIUM 519 506 6 4
PLAVIX 474 458 7 14
METOPROLOL SUCCINATE 474 456 7 1
NEXIUM 469 462 9 34
EVISTA 405 382 10 73
EXFORGE 399 397 11 80
CILOSTAZOL 383 376 12 90
CARVEDILOL 381 377 13 8
LOVAZA 380 368 14 37
LIDODERM 356 352 15 76
ALENDRONATE SODIUM 353 338 16 46
ATENOLOL 325 302 17 11
CLOPIDOGREL 312 300 18 12
FUROSEMIDE 276 270 19 5
METFORMIN HCL 267 262 20 26
SINGULAIR 265 262 21 93
ISOSORBIDE MONONITRATE ER 261 261 22 17
WARFARIN SODIUM 260 243 23 9
CRESTOR 255 233 24 10
COLCRYS 247 242 25 135
TAMSULOSIN HCL 236 234 26 38
ALLOPURINOL 223 223 27 47
JANUVIA 222 222 28 45
LIPITOR 218 210 29 24
MULTAQ 216 198 30 89
EXFORGE HCT 209 204 10 31 151
DIGOXIN 201 189 32 15
RAMIPRIL 193 179 33 18
LOSARTAN POTASSIUM 182 182 34 13
ACTONEL 176 176 35 167
SPIRONOLACTONE 168 168 36 28
ADVAIR DISKUS 166 166 37 79
LOSARTAN-HYDROCHLOROTHIAZIDE 165 153 38 30
GLIMEPIRIDE 155 153 39 67
AVODART 152 152 40 145
CLOBETASOL PROPIONATE 151 150 41 190
DONEPEZIL HCL 150 150 42 62
JANUMET 140 130 43 109
TRICOR 130 128 44 100
VOLTAREN 128 125 45 137
OMEPRAZOLE 123 123 46 21
CELEBREX 117 116 47 138
HYDROCHLOROTHIAZIDE 112 112 48 16
NAMENDA 105 105 49 91
ACTOS 104 102 50 110
TRILIPIX 100 100 51 104
ZOLPIDEM TARTRATE 94 93 52 25
COMBIVENT 93 89 53 179
MECLIZINE HCL 92 91 54 83
LEVOTHYROXINE SODIUM 89 77 55 22
VYTORIN 88 88 56 101
COUMADIN 88 65 56 41
NIASPAN 83 74 58 57
LISINOPRIL 83 68 58 7
NASONEX 80 80 60 200
PREDNISONE 80 77 60 111
NIFEDIPINE ER 80 73 60 39
FENOFIBRATE 80 74 60 82
AZITHROMYCIN 77 73 64 56
MICARDIS 76 76 65 126
RANEXA 75 75 66 29
PRADAXA 75 56 66 27
METOPROLOL TARTRATE 74 58 68 6
GLIPIZIDE XL 73 73 69 107
PATANOL 71 71 70 232
SOLARAZE 70 68 71 196
ZETIA 69 59 72 31
ANTARA 68 68 73 313
LYRICA 68 68 73 188
VALSARTAN-HYDROCHLOROTHIAZIDE 67 64 75 222
CLOTRIMAZOLE-BETAMETHASONE 66 66 76 118
METFORMIN HCL ER 65 65 77 71
BISOPROLOL FUMARATE 63 63 78 60
MONTELUKAST SODIUM 63 62 78 193
FINASTERIDE 60 60 80 87
ACTOPLUS MET 59 52 81 269
BISOPROLOL-HYDROCHLOROTHIAZIDE 58 53 82 106
AMMONIUM LACTATE 56 47 83 156
MOMETASONE FUROATE 54 50 84 256
EFFIENT 50 48 85 98
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 5, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.